This book provides a source of much needed and up-to-date information on the products and applications of nanotechnology for the food sector - for scientists, regulators, and consumers alike. It also gives an independent, balanced, and impartial view of the potential benefits as well as risks that nanotechnology applications may bring to the food sector. Whilst providing an overview of the state-of-the-art and foreseeable applications to highlight opportunities for innovation, the book also discusses areas of uncertainty in relation to public perception of the new technological developments, and potential implications for consumer safety and current regulatory controls. The book also discusses the likely public perceptions of nanotechnologies in the light of past technological developments in the food sector, and how the new technology will possibly be regulated under the existing regulatory frameworks.

Recent developments in the field of nanotechnology have paved the way for lots of innovation in a number of industrial and consumer sectors, including food and food packaging. Whilst nanofood sector is a relatively new emergent, it is widely expected to grow rapidly in the future. A number of nano-sized additives and supplements for food and healthfood products, and nanotechnology derived food packaging materials, are already available in some countries, and their number is expected to increase in the coming years. Whilst such developments offer enormous benefits to the food sector, they have also raised a number of issues in relation to consumer safety, environmental impacts, and ethical, policy and regulatory aspects.

Despite these rapid developments in nanotechnology applications for the food sector, prior to this book only a few reports and articles were available that provide an account of the new developments and the current size of market for nanotechnology products and applications. These do not provide a critical evaluation of the broader aspects of the technology, such as issues around safety of the products to consumers and the environment, and adequacy of the existing regulatory controls.

A cutting-edge analysis of the global issues surrounding modern reproductive technologies Advances in assisted reproductive technologies have sparked global policy debates since the birth of the first so-called "test tube baby" in 1978. Today, mitochondrial replacement therapies represent the most recent advancement in assisted reproductive technologies, allowing some women with mitochondrial diseases to birth babies without those diseases. In the past decade, mitochondrial replacement therapies have captured public sentiment, reigniting debates around social views of reproductive rights and the appropriate legal and political response. Reproduction Reborn guides readers through the history and science of mitochondrial replacement therapies and the various attempts to control them. Leading experts from medicine, genetics, ethics, law, and policy explore the influence of public debate on the evolving shape of these technologies and their subsequent regulation. They highlight case studies from both developed and developing countries across the globe, including recent legislation in Australia and China. They further identify the ethical, legal, and societal norms that need to be addressed by policymakers and communities as more and more people seek to gain access to these treatments. Given the importance of reproduction in family life and cultural identity, clinicians and policymakers must understand how regulatory regimes around mitochondrial replacement therapies have evolved to illuminate the processes and challenges of governing reproduction in a fast-moving world. Informative and global in scope, Reproduction Reborn explores how advancements in assisted reproductive technologies challenge core values surrounding the rights and responsibilities of modern-day family units.

A cutting-edge analysis of the global issues surrounding modern reproductive technologies Advances in assisted reproductive technologies have sparked global policy debates since the birth of the first so-called "test tube baby" in 1978. Today, mitochondrial replacement therapies represent the most recent advancement in assisted reproductive technologies, allowing some women with mitochondrial diseases to birth babies without those diseases. In the past decade, mitochondrial replacement therapies have captured public sentiment, reigniting debates around social views of reproductive rights and the appropriate legal and political response. Reproduction Reborn guides readers through the history and science of mitochondrial replacement therapies and the various attempts to control them. Leading experts from medicine, genetics, ethics, law, and policy explore the influence of public debate on the evolving shape of these technologies and their subsequent regulation. They highlight case studies from both developed and developing countries across the globe, including recent legislation in Australia and China. They further identify the ethical, legal, and societal norms that need to be addressed by policymakers and communities as more and more people seek to gain access to these treatments. Given the importance of reproduction in family life and cultural identity, clinicians and policymakers must understand how regulatory regimes around mitochondrial replacement therapies have evolved to illuminate the processes and challenges of governing reproduction in a fast-moving world. Informative and global in scope, Reproduction Reborn explores how advancements in assisted reproductive technologies challenge core values surrounding the rights and responsibilities of modern-day family units.

Nanotechnology Environmental Health and Safety tackles - in depth and in breadth - the complex and evolving issues pertaining to nanotechnology's environmental health and safety (EHS). The chapters are authored by leaders in their respective fields, providing thorough analysis of their research areas. The diverse spectrum of topics include nanotechnology EHS issues, financial implications, foreseeable risks including exposure, dosage and hazards, and the implications of occupational hygiene precautions and consumer protections. The book includes real-world case studies, wherever practical, to illustrate specific issues and scenarios encountered by stakeholders positioned on the front-lines of nanotechnology-enabled industries. These case studies will appeal to, and resonate with, laboratory scientists, business leaders, regulators, service providers, and postgraduate researchers.

"Nanotechnology Environmental Health and Safety, Second Edition" focuses not only on the impact of nanotechnology and the discipline of nanotoxicity, but also explains each of these disciplines through in the context of management requirements and via risk scenarios providing an overview of regulation, risk management, and exposure. Contributors thoroughly explain environmental health and safety (EHS) issues, financial implications, foreseeable risks (e.g., exposure, dose, hazards of nanomaterials), occupational hygiene, and consumer protection.

Key new chapters have been included covering eco-toxicity, nanomedicine, informatics, and future threats. New case studies have also been added, including a chapter on the impact of nanosilver on the environment, as well as an assessment of how well lessons have been learned from the past, such as in the case of asbestos. The book also makes a business case for the importance of proactive EHS management - essential reading for existing or prospective producers of nanoscale products.
Practical guidance on risk management and mitigation across different legislative frameworks worldwideReviews toxicological studies and industrial initiatives, supported by numerous case studiesIncludes extensive newmaterial on the implications of nanotechnology for medicine, energy and food, as well as assessing future threats."